Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Newman

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Psychopharmacology|May 15, 2001
Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodentsJ L Katz, G E Agoston, K L Alling, et al.
Psychopharmacology|February 15, 2013
Divergent effects of D₂/₃ receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive ratsM Moreno, D Economidou, A C Mar, et al.
Journal of Medicinal Chemistry|July 24, 1992
Probes for narcotic receptor mediated phenomena. 18. Epimeric 6 alpha- and 6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinans as potential ligands for opioid receptor single photon emission computed tomography: synthesis, evaluation, and radiochemistry of [125I]-6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinanB R de Costa, M J Iadarola, R B Rothman, et al.
Cell Chemical Biology|December 4, 2025
Targeted inhibition of mu-opioid receptors in neuronal subpopulations by membrane-tethered Naloxo-DART antagonistsJ Sanchez, A Bonifazi, S Groom, et al.
Iscience|June 22, 2023
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopyDaniel M Williams, Hailey R Hornsby, Ola M Shehata, et al.
Mbio|September 1, 2023
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH studyIsabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Cell Reports|March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responsesAiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Psychopharmacology|May 15, 2001
Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodentsJ L Katz, G E Agoston, K L Alling, et al.
Psychopharmacology|February 15, 2013
Divergent effects of D₂/₃ receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive ratsM Moreno, D Economidou, A C Mar, et al.
Journal of Medicinal Chemistry|July 24, 1992
Probes for narcotic receptor mediated phenomena. 18. Epimeric 6 alpha- and 6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinans as potential ligands for opioid receptor single photon emission computed tomography: synthesis, evaluation, and radiochemistry of [125I]-6 beta-iodo-3,14-dihydroxy-17-(cyclopropylmethyl)-4,5 alpha-epoxymorphinanB R de Costa, M J Iadarola, R B Rothman, et al.
Cell Chemical Biology|December 4, 2025
Targeted inhibition of mu-opioid receptors in neuronal subpopulations by membrane-tethered Naloxo-DART antagonistsJ Sanchez, A Bonifazi, S Groom, et al.
Iscience|June 22, 2023
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopyDaniel M Williams, Hailey R Hornsby, Ola M Shehata, et al.
Mbio|September 1, 2023
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH studyIsabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Cell Reports|March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responsesAiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Pageof 7